The use of Pluronic lecithin organogels in the transdermal delivery of drugs.
This article provides a brief and basic discussion of Pluronic lecithin organogel to include its history, its components, its mechanism of action, the range of active pharmacological agents that can and cannot be incorporated into a Pluronic lecithin organogel, as well as important information for those pharmacists who compound Pluronic lecithin organogel.
Walgreens, West Plains, Missouri 65775, USA. bethany.bramwell@walgreens.com
Bethany L
BL
Bramwell
LaVonn A
LA
Williams
D000279:Administration, Cutaneous; D016503:Drug Delivery Systems; D004355:Drug Stability; D005782:Gels; D006801:Humans; D054709:Lecithins / Q000008:administration & dosage*; D020442:Poloxamer / Q000008:administration & dosage*; D012867:Skin / Q000378:metabolism*
D005782:Gels; D054709:Lecithins; D020442:Poloxamer